Logotype for RxSight Inc

RxSight (RXST) investor relations material

RxSight Morgan Stanley 23rd Annual Global Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for RxSight Inc
Morgan Stanley 23rd Annual Global Healthcare Conference summary8 Sep, 2025

Market trends and dynamics

  • Cataract surgery volumes in the U.S. saw an unexpected decline at the start of the year, with some patients delaying procedures or opting for less expensive monofocal lenses due to macroeconomic factors.

  • Premium intraocular lens (IOL) demand remained more stable, with toric lenses gaining favor due to their high quality and minimal side effects.

  • Medicare reimbursement cuts for monofocal lenses are pushing practices to convert more patients to premium options to maintain profitability.

  • Private equity-backed ophthalmology practices are incentivized to increase premium lens adoption, leveraging broader practice teams to drive growth.

  • Increased competition in the premium IOL market, with new entrants and product launches, has intensified market dynamics and share shifts.

Company strategy and operational changes

  • Recent cohorts of new customers have adopted Light Adjustable Lens (LAL) technology more slowly, prompting a shift in sales and clinical support structure.

  • The company combined its LAL sales and clinical teams by territory to better support customer onboarding and practice conversion, aiming for improved account growth.

  • Ongoing investment in clinical support staff is planned as the installed base grows, with a focus on optimizing customer experience and outcomes.

  • The company is prioritizing targeted customer selection and learning from new account ramp-up to refine growth strategies through 2025.

International expansion and market opportunities

  • Early commercialization has begun in Europe and South Korea following regulatory approvals, with further expansion planned in major global markets.

  • The company is leveraging U.S. clinical data and experience to support international launches, focusing on building local key opinion leader (KOL) support.

  • International markets are more fragmented, requiring tailored strategies for each country, but represent a significant growth opportunity as 80% of premium lenses are sold outside the U.S.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next RxSight earnings date

Logotype for RxSight Inc
Q3 20256 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next RxSight earnings date

Logotype for RxSight Inc
Q3 20256 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

RxSight Inc. is a medical technology company focused on developing and commercializing adjustable intraocular lenses (IOLs) for patients undergoing cataract surgery. The company's flagship product, the Light Adjustable Lens (LAL), allows for non-invasive adjustments to the lens after implantation, improving visual outcomes. RxSight's technology provides cataract patients with more precise vision correction by enabling post-surgical adjustments tailored to individual needs. The company is headquartered in Aliso Viejo, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage